Stock Analysis
- New Zealand
- /
- Healthcare Services
- /
- NZSE:MEE
Me Today Full Year 2024 Earnings: NZ$0.41 loss per share (vs NZ$0.85 loss in FY 2023)
Me Today (NZSE:MEE) Full Year 2024 Results
Key Financial Results
- Revenue: NZ$5.03m (down 36% from FY 2023).
- Net loss: NZ$11.3m (loss narrowed by 13% from FY 2023).
- NZ$0.41 loss per share (improved from NZ$0.85 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Me Today's share price is broadly unchanged from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 5 warning signs for Me Today (4 don't sit too well with us!) that you need to be mindful of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NZSE:MEE
Me Today
Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.